Skip to main content
. 2022 Sep 7;9:912474. doi: 10.3389/fcvm.2022.912474

TABLE 3.

General features, cardiovascular profile, and ECG measurements in the subgroups of patients with arrhythmia.

B (n = 12) T (n = 57) BT (n = 11) p-value
General findings
Age (years) 64.5 (67–80.5) 79 (74–79) 79 (66–87) 0.89
Death n (%) 2 (16.7) 16 (28.1) 2 (18.2) 0.61
Comorbidities 3.5 (2–5) 3 (2–4) 3 (2–4) 0.44
Lung computed tomography score 8 (5–15) 8 (5–12) 8 (7–9) 0.96
Lung ultrasound score 8 (5–15) 13.5 (7–20) 11 (4–14) 0.48
Main cardiovascular morbidities
Arterial hypertension n (%) 8 (66.6) 39 (68.4) 8 (72.7) 0.78
Coronary artery disease n (%) 3 (25) 16 (28.1) 3 (27.3) 0.98
Heart failure n (%) 1 (8.3) 9 (15.8) 2 (18.2) 0.77
Any prior arrhythmia n (%) 6 (50) 23 (40.3) 5 (45.5) 0.67
ICD/PPM n (%) 4 (33.3) 4 (7.0) 2 (18.2) 0.03
ECG parameters
QT (msec)
At admission 380 (355–430) 360 (340–420) 370 (360–450) 0.23
At dischargea 380 (360–415) 360 (320–380) 380 (360–415) 0.08
QTc (msec)
At admission 425 (385–430) 410 (390–440) 420 (395–420) 0.77
At dischargea 380 (370–440) 390 (380–440) 390 (386–425) 0.21
QTc dispersion (msec)
At admission 95 (85–110) 80 (50–110) 85 (70–90) 0.25
At dischargea 70 (50–90) 70 (50–90) 65 (50–75) 0.71

aCalculated in 60 patients; values are presented as median (interquartile range) or as n (%).

B, patients with brady-arrhythmia; BT, patients with brady- and tachy-arrhythmia; ICD/PPM, implantable cardioverter-defibrillator/permanent pacemaker; QTc, heart rate-corrected QT interval; T, patients with tachy-arrhythmia.